Radar · Industry landscape · the United Kingdom
Life Sciences Landscape of the United Kingdom
3,337 Life Sciences companies in the United Kingdom, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated August 2026.
3,337companies tracked
$36.7Bdisclosed funding
163hiring right now
1,570events · 24 months
125,175news articles · 12 months
Who leads Life Sciences in the United Kingdom
The page lists 3,337 UK life‑sciences firms, highlighting the top hiring companies such as LivaNova, Cytiva and ViiV Healthcare, and the best‑funded firms like Isomorphic Labs, Nanopore Technologies and CMR Surgical; 163 are hiring now and 1,026 have disclosed a funding round.
open roles
Hiring now
ranked by live open roles
- 01
LivaNova11last posted Jun 2026
- 02
Cytiva10last posted Jul 2026
- 03
ViiV Healthcare10last posted Jun 2026
- 04
SPT Labtech9last posted Jun 2026
- 05
Theramex8last posted May 2026
- 06
COMPASS Pathways7last posted Jun 2026
- 07
Stallergenes Greer7last posted Apr 2026
- 08
mobius mobility7last posted May 2026
163 companies hiring · 3 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
- 01
Isomorphic Labs$2.7BSeries B · May 2026
- 02
Nanopore Technologies$1.4BPost IPO · Aug 2024
- 03
CMR Surgical$1.4BSeries D · Apr 2025
- 04
Immunocore$896.3MPost IPO · Jul 2022
- 05
Bicycle$645.1MPost IPO · May 2024
- 06
Orchard Therapeutics$610.3MPost IPO · Mar 2023
- 07
Exscientia$595.8MGrant (prize money) · Dec 2023
- 08
MiNA Therapeutics$461.6MSeries A · Jul 2021
1,026 companies with disclosed rounds · $36.7B total
revenue
Revenue leaders
official filings first, else latest snapshot
- 01
Oxford Instruments$633.8MFY2023 filing
- 02
- 03
- 04
Judges Scientific$140Msnapshot Dec 2022
- 05
- 06
- 07
Welland Medical$58.4Msnapshot Dec 2024
- 08
55 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
- 01
- 02
Bespak2,000tracked employees
- 03
ConvaTec Group971tracked employees
- 04
Epredia863tracked employees
- 05
Advanced Medical Solutions719tracked employees
- 06
- 07
- 08
Allergy Therapeutics601tracked employees
287 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
- 01
Sinclair3.5%73 tracked events
- 02
Biodexa Pharmaceuticals2.6%53 tracked events
- 03
- 04
Avita Medical2.2%46 tracked events
- 05
Cresset2.1%43 tracked events
- 06
- 07
- 08
Rapid Micro Biosystems1.9%40 tracked events
2,071 tracked events across 322 companies
articles
In the news
Prism news coverage, last 12 months
- 01
Rayner1,056articles in the window
- 02
Abcam218articles in the window
- 03
imc171articles in the window
- 04
Verona Pharma97articles in the window
- 05
New England Biolabs85articles in the window
- 06
- 07
- 08
Medicina55articles in the window
353 of these companies drew sector coverage in the window
Radar
See all 3,337 Life Sciences companies in the United Kingdom
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in the United Kingdom grew, 2016–2025
It shows the number of companies founded each year, with a peak of 212 new firms in 2020 and only 24 founded so far in 2025.
Companies founded / year
new Life Sciences companies in the United Kingdom
20162025
peak 212 in 2020
Companies raising / year
with a disclosed round that year
20162025
peak 240 in 2021
Disclosed funding / year
sum of disclosed rounds (USD)
20162025
peak $5.5B in 2021
Where Life Sciences companies in the United Kingdom are based
Hub 01
London
739 Life Sciences companies
52% of the Life Sciences companies across these hubs
739companies
$12.7Bdisclosed funding
39hiring now
Hub 02
Cambridge
268 Life Sciences companies
19% of the Life Sciences companies across these hubs
268companies
$8.3Bdisclosed funding
23hiring now
Hub 03
Oxford
148 Life Sciences companies
10% of the Life Sciences companies across these hubs
148companies
$4.6Bdisclosed funding
8hiring now
Hub 04
Edinburgh
74 Life Sciences companies
5% of the Life Sciences companies across these hubs
74companies
$978.7Mdisclosed funding
3hiring now
Hub 05
Manchester
64 Life Sciences companies
5% of the Life Sciences companies across these hubs
64companies
$758.8Mdisclosed funding
4hiring now
Hub 06
Glasgow
42 Life Sciences companies
3% of the Life Sciences companies across these hubs
42companies
$314Mdisclosed funding
3hiring now
Hub 07
Sheffield
42 Life Sciences companies
3% of the Life Sciences companies across these hubs
42companies
$57.1Mdisclosed funding
4hiring now
Hub 08
Cardiff
40 Life Sciences companies
3% of the Life Sciences companies across these hubs
40companies
$316.3Mdisclosed funding
2hiring now
The Life Sciences market map of the United Kingdom: what these companies actually do
It breaks down the main product categories, showing enterprise tech as the largest with 2,193 companies, and lists the most common revenue models such as physical commerce (1,461 firms) and e‑commerce product sales (1,293 firms).
- Enterprise Tech2,193 companies · $33.4B raised · 130 hiring
- Healthtech724 companies · $5.6B raised · 48 hiring
- Medical Devices700 companies · $5.4B raised · 42 hiring
- Biopharmaceuticals574 companies · $18.7B raised · 33 hiring
- Consumer Digital542 companies · $1.3B raised · 20 hiring
- Enterprise Software533 companies · $3B raised · 38 hiring
- Deep Tech489 companies · $11.4B raised · 29 hiring
- Nutritional Formula192 companies · $158M raised · 6 hiring
- In Vitro Diagnostics180 companies · $1.1B raised · 7 hiring
- SaaS178 companies · $1.2B raised · 16 hiring
- Healthtech SaaS144 companies · $1.1B raised · 16 hiring
- Chronic Disease Management105 companies · $230.8M raised · 7 hiring
Monetization
How Life Sciences companies make money
How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Physical Commerce1,461
E-Commerce - Product1,293
Subscription1,104
Fee-For-Service530
Commission on Transaction98
Advertising64
E-Commerce - Service37
Sponsorship8
Funding, M&A and the deals moving Life Sciences in the United Kingdom
Funding 379Leadership 301Earnings 299M&A 212Contracts 86Announcement 78Assets 42IPO 41Capital 31Regulatory 27
- FundingPlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease, has raised $5 million.2026-04-28
- M&AAdvanced Medical Solutions said on Monday that it is in negotiations with U.S. private equity firm TA Associates over a potential takeover of the British medical supplier.2026-04-21
- FundingSTORM Therapeutics, a Cambridge-based clinical-stage biotech company focused on RNA-targeted cancer therapies, has raised $56 million in Series C funding.2026-04-18
- M&ACreo Medical Group has entered into an agreement to sell its manufacturing operations to Creo’s current manufacturing operations management as a management buyout for an undisclosed amount.2026-04-16
- M&AHerbalife acquired the personalized nutrition company Bioniq2026-04-14
- M&AH.I.G. Capital-backed Vernacare has acquired Cardiff-based Eakin Surgical from Eakin Healthcare Group.2026-04-10
- FundingAdvanced skincare and cosmetics company Corryn Biotechnologies has secured a £500,000 equity investment to support commercialisation and scale-up of its cosmetic aftercare products in the UK and US.2026-04-06
- M&ADigital Science’s acquisition of Ontopic aims to enhance research intelligence and knowledge discovery through advanced data integration and extraction technologies.2026-03-30
- M&ARoquefort has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines.2026-03-28
- FundingAvacta Group plc (...) has completed an oversubscribed equity raise of £10 million gross proceeds through a placing of 15,000,000 new ordinary shares and a director subscription for a further 873,016 shares2026-03-27
Mergers and acquisitions
Deals from the last 24 months where a Life Sciences company in the United Kingdom was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
| Acquirer | Target | Deal value | Status | Date |
|---|---|---|---|---|
| undisclosed | Rumored | 2026-04-21 | ||
| undisclosed | Announced | 2026-04-16 | ||
| undisclosed | Completed | 2026-04-14 | ||
| undisclosed | Completed | 2026-04-14 | ||
| undisclosed | Announced | 2026-04-09 | ||
| undisclosed | Announced | 2026-03-30 |
Who is listing, hiring leaders, launching and winning work
This view details specific events like IPO filings, leadership changes, product launches and contract wins for the companies in the sector.
IPO pipeline
25 companies listed or filing · last 24 months
OKYO PharmaFollow-on Offering · Nasdaq Capital Market · OKYO · 2 reportsFeb 2026
tc biopharmIPO · Nasdaq · 1 reportNov 2025
genedrive plcFollow-on Offering · AIM · GDR · 1 reportOct 2025
NuCanaFollow-on Offering · Nasdaq · NCNA · 1 reportSep 2025
Oxford GlycoSciencesIPO · London Stock Exchange · OGS · 4 reportsFeb 2025
Leadership moves
93 tracked people moves · last 12 months
CellmarkNeil Gosbee · Appointment → Division PresidentApr 2026
uMotifSteve Rosenberg · Appointment → Chief Executive OfficerApr 2026
4basebioDavid Roth · Departure — was CFO and directorMar 2026
Contract wins
48 customer wins · last 24 months
Sitryxwon boehringer ingelheimFeb 2026
Aptamer Groupwon undisclosed clientJan 2026
3D Bio-Tissueswon seawithDec 2025
Proteome Scienceswon US biopharmaceutical companyDec 2025
SkinBioTherapeuticswon superdrug storesDec 2025
Workforce actions
11 companies cutting roles · last 24 months
Replimune~224 roles reported · regulatory setbackApr 2026
Bit.bio~25% of workforce reported · cost reductionJan 2026
CeNeS Pharmaceuticals~17 roles reported · cost reductionFeb 2025
Acambis~40 roles reported · strategic reviewFeb 2025
Regulatory & litigation
29 regulatory events · 8 tracked suits · 24 months
Markenapproved for storage and distributionJan 2026
- Class Period purchasers v mereo biopharmaInvestor damages due to alleged misstatements of clinical trial outcomes · OngoingApr 2026
- all persons or entities who purchased or otherwise acquired v mereo biopharmaMisleading statements about Phase 3 studies leading to inflated share price · FiledFeb 2026
Earnings pulse
companies reporting results · last 24 months
69 companies reporting326 company-quarters trackedbeat 31miss 22in line 2
Half of these companies grew revenue faster than +20.0%, half slower.
Who is building Life Sciences in the United Kingdom
The data profiles 2,359 founders and CEOs across 1,659 firms, noting that the most common alma maters are Cambridge (140) and Oxford (106), and the most frequent prior employers are McKinsey (7) and Boston Consulting Group (5).
Founders and chief executives12 of 2,359, from the best-funded companies on this page
University of the Witwatersrand MB, University of Cape Town, University of Cambridge MA
Ex-Pfizer
Kings College in London
Rice University BS 2005, University of Utah PhD 2013 & MD 2016
Ex-Stirling Square Capital Partners, EMcision, Deutsche Bank. University of Bristol BSc 2007, Columbia Business School MBA 2013
CEO - cellcentric. London Business School Master of Business Administration 2001
Ex-MannKind, Medtronic, GE Healthcare, GE Appliances. Indiana University Bloomington MBA 2004, MS 2005
Ex-Vyome Therapeutics, Aratana Therapeutics, Ikaria · Kalamazoo College BA 1988, The University of Chicago Booth School of Business MBA 1992
Ex-Co-Founder Aiolos Bio, Gyroscope Therapeutics. Wolverhampton University, Aston University MBA
Where the founders studied
alma mater on record for 522 of 2,359 founders
University of Cambridge140
University of Oxford106
Imperial College London70
University College London48
University of Bristol32
University of Manchester26
University of Warwick18
INSEAD15
Where they worked before
a previous employer on record for 24 of 2,359 founders
McKinsey7
Boston Consulting Group5
Goldman Sachs4
Bain3
Microsoft2
Morgan Stanley1
Google1
Facebook1
Founders flagged as repeat founders
of 2,071 founders with a profile on this page
15
carry a repeat-founder flag
- flagged as repeat founders15
- no repeat-founder flag2,056
Radar
Look up the people behind Life Sciences companies in the United Kingdom
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in the United Kingdom
It records 2,651 funding rounds since 2016 from 1,589 investors, with the typical round size being $2.1 million.
| Investor · most active investors since 2016 | Rounds | Led | Latest |
|---|---|---|---|
| Europa | 155 | 1 | Dec 2023 |
| Gov | 83 | 1 | Sep 2025 |
| Mercia | 60 | 42 | May 2026 |
| Scottish Enterprise | 58 | 11 | Apr 2026 |
| Ukri | 57 | 1 | Jan 2026 |
| Oxford Science Enterprises | 47 | 17 | Nov 2025 |
| UK Innovation Science & Seed Fund | 47 | 16 | Mar 2026 |
| Parkwalk | 44 | 20 | Nov 2025 |
| Oxford Technology | 43 | 7 | Apr 2026 |
| Cambridge Innovation Capital | 37 | 12 | Mar 2026 |
Stage mix · rounds since 2016
Seed & Angel1,043
Series A–B733
Series C+ / PE117
Grants, debt & other758
The typical round is $2.1M — half were bigger, half smaller.
The biggest Life Sciences funding rounds in the United Kingdom
The largest disclosed round is Isomorphic Labs’ $2.1 billion Series B, and ten other large rounds are listed.
| Company | Round | Size | When | Backers |
|---|---|---|---|---|
| Series Bmega-round | $2.1B | May 2026 | Thrive Capital, Alphabet, Google Ventures +4 more | |
| Series Dmega-round | $600M | Jun 2021 | Ally Bridge Group, Railpen, Tencent +7 more | |
| Series Amega-round | $600M | Mar 2025 | Thrive Capital, Google Ventures, Alphabet | |
| Series Amega-round | $411M | Jan 2025 | Forbion, General Atlantic, RA Capital Management +4 more | |
| Series Amega-round | $355.7M | Nov 2017 | Boehringer Ingelheim | |
| Series Bmega-round | $320M | Jul 2015 | Lilly, Woodford Investment Management, RTW Investments | |
| Series Cmega-round | $274M | Sep 2019 | Escala Capital, Watrium, Zhejiang SilkRoad Fund +3 more | |
| Series Hmega-round | $270.5M | May 2021 | M&G, Temasek, Wellington +1 more | |
| Series D | $245M | Jun 2021 | Novo Holdings, BlackRock, Eldridge Industries +8 more | |
| Series C | $226.5M | Sep 2023 | Patient Square Capital, M&G, Rock Springs Capital |
Venture round sizes · 2023–2025
<$1M107
$1–10M192
$10–50M99
$50–250M33
>$250M2
433 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Series D$220MMay 2026
Series A$83MMay 2026
Seed$6.7MMay 2026
Series A$5.9MMay 2026
Series A$3.8MMay 2026
Conventional Debt$2.7MMay 2026
Seed$2.4MMay 2026
What the news says about Life Sciences in the United Kingdom
In the last year, 125,175 news articles covered the sector, focusing on topics such as COVID‑19 vaccine development, oncology advances, and international political and security issues.
News volume
Life Sciences coverage across United Kingdom · articles per quarter
2021Q22026Q1
peak 55,105 in 2025Q1 · 125,175 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative)
202120232025
Positive-tone share moved 63% → 69%, negative 36% → 29% across 2021–2025.
What the coverage is about
The subjects that dominate Life Sciences news in United Kingdom. The arrow shows whether each one is being written about more or less than a year ago.
- Covid-19 vaccine development and efficacy trials12,681▲+37%
- International political relations9,929▲+65%
- Security and defense policies6,994▲+58%
- Oncology and targeted therapy advancements6,838▼-15%
- Covid-19 vaccination campaigns and rollout strategies6,487▲+52%
- Economy news: inflation rate analysis6,211▲+27%
- Rare disease therapies and orphan drugs5,780▼-32%
- Drug pricing and reimbursement strategies5,713▲+47%
- Vaccine research and production methods5,326▼-55%
- International relations and diplomacy4,715▲+41%
Most-covered companies · last 12 months
- 1,056
- 218
- 171
- 97
- 85
- 82
- 63
- 55
- 53
- 40
353 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in United Kingdom as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter
Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
tariff negotiations+136%angel investors+151%free trade deals+170%vaccine candidates+55%bilateral trade+318%vaccine immunogenicity+78%trade dispute mechanisms+173%vaccination campaigns+197%asset acquisition+193%early-stage investment+199%
investigational new vaccine-73%vaccine formulation-62%viral vector vaccines-67%diagnostic biotechnology-52%vaccine preclinical testing-73%
The pressures the press keeps returning to
Three recurring angles in United Kingdom Life Sciences coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk ▲ rising
164,440 articles touch this dimension · 54.0% critical tone
20212025
signals: inflation outlook, core inflation rate, inflation breakdown
Funding Momentum ▲ rising
47,225 articles touch this dimension · 45.5% critical tone
20212025
signals: angel investors, early-stage investment, asset acquisition
Growth ▲ rising
93,708 articles touch this dimension · 38.3% critical tone
20212025
signals: gdp acceleration, gdp growth rate, inflation outlook
Life Sciences jobs in the United Kingdom: who is hiring and what they ask for
The section lists 55 job postings from 17 employers in the past year, with the most‑requested skills including Python, SAS, Excel, Java and Git.
55postings · last 12 months
293postings tracked overall
17employers advertising
Demand
The Skills Employers Ask For
What Life Sciences employers in the United Kingdom put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
- python35▲
- sas33▼
- excel24▼
- java19→
- git19▲
- c++16▲
- machine learning15▲
- word15▼
- typescript14▲
- sql14→
Most advertised titles
- 2
- 2
- 2
- 1
- 1
- 1
What Life Sciences research is working on
It catalogues 53,147 academic papers, of which 4,958 identify common problems, 1,880 issue cautions, and 23,660 highlight opportunities.
How this field talks about itself
Life Sciences papers (gold) against all published research (grey)
Descriptive40.2% · 17.8%2.3×
Promising30.4% · 37.0%0.8×
Breakthrough14.1% · 26.1%0.5×
Problem-identifying8.3% · 10.0%0.8×
Cautionary3.5% · 4.3%0.8×
Comparative2.4% · 3.9%0.6×
Life Sciences literature runs 2.3× more “descriptive” than science at large (40.2% vs 17.8% baseline).
How the work is done
Empirical48.8%
Reviews37.2%
Methods-led11.2%
Position pieces2.2%
Theoretical0.6%
How the research reads
80% positive · 16% neutral · 4% negative, across 53,147 papers.
The institutions behind the field
- 87k
- 75k
- 61k
- 49k
- 43k
- 38k
ranked by how often their work is cited
Researchers who shaped it
Ahmad Almilaji · Reiki Nishimura · Tomofumi Osako · Yasuyuki Nishiyama · Rumiko Tashima · Masahiro Nakano · Glenn R. Gibson · Gregor Reid
The most-cited breakthroughs
- Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity · 9k cites
- In situ click chemistry generation of cyclooxygenase-2 inhibitors · 8k cites
- U1 snRNP regulates cancer cell migration and invasion in vitro · 7k cites
- Comprehensive molecular profiling of lung adenocarcinoma · 6k cites
- Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal · 6k cites
Common problems researchers identify4,503 papers · 7 recurring themes
Problems · theme 01
Sustainable Biofuel and Biomass Production
781 papers · 17.3% of this block
▲ +11% share2022→2025 share of research on this subject
Challenges in using microbes and plants for renewable fuels and biorefinery processes.
Biofuel · Synthetic biology · Biomass · Biorefinery
“A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application”
781 of these papers raise it as a problem
Problems · theme 02
Food Safety and Processing Risks
757 papers · 16.8% of this block
▲ +41% share2022→2025 share of research on this subject
Issues surrounding microbial hazards, nutritional quality, and health impacts of processed foods.
Food safety · Food processing · Food products · Human health
“Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures”
757 of these papers raise it as a problem
Problems · theme 03
Gene Expression and mRNA Therapeutics
711 papers · 15.8% of this block
▼ -31% share2022→2025 share of research on this subject
Barriers in controlling gene activity, mRNA delivery, and cell‑culture models for disease research.
Messenger RNA · Gene · Cell culture · Gene expression
“Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research”
711 of these papers raise it as a problem
Problems · theme 04
Crop Nutrition and Food Security
693 papers · 15.4% of this block
▲ +23% share2022→2025 share of research on this subject
Limitations in fertilizer use, nutrient uptake, and breeding for resilient, high‑yield crops.
Agriculture · Crop · Food security · Germplasm
“Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants”
693 of these papers raise it as a problem
Problems · theme 05
Plant Disease Management
691 papers · 15.3% of this block
▲ +35% share2022→2025 share of research on this subject
Complexities of fungicide resistance, host‑pathogen interactions, and integrated pest strategies.
Fungicide · Integrated pest management · Host · Disease management
“Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens”
691 of these papers raise it as a problem
Problems · theme 06
Antimicrobial Resistance Across Sectors
447 papers · 9.9% of this block
▲ +10% share2022→2025 share of research on this subject
Rising drug‑resistant bacteria in humans, livestock, and the environment.
Antibiotic resistance · Antimicrobial · Antibiotics · Drug resistance
“Antimicrobial resistance in humans, livestock and the wider environment”
447 of these papers raise it as a problem
Problems · theme 07
Miscellaneous Biological and Chemical Topics
423 papers · 9.4% of this block
▼ -32% share2022→2025 share of research on this subject
Broad, unrelated research areas lacking a clear thematic focus.
Order · NAD+ kinase · Human being · Sodium
“Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar”
423 of these papers raise it as a problem
Cautions1,765 papers · 7 recurring themes
Cautions · theme 01
Cellular Toxicity and Oxidative Stress
379 papers · 21.5% of this block
▼ -20% share2022→2025 share of research on this subject
Need for careful interpretation of in‑vitro and in‑vivo assays measuring stress responses.
In vivo · Flow cytometry · In vitro · Oxidative stress
“Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells”
379 of these papers raise it as a problem
Cautions · theme 02
Genomic Selection in Plant Breeding
257 papers · 14.6% of this block
▲ +25% share2022→2025 share of research on this subject
Caution about translating theoretical genomic tools into practical crop improvement.
Agriculture · Selection · Production · Trait
“Genomic selection in plant breeding: from theory to practice”
257 of these papers raise it as a problem
Cautions · theme 03
Feed Additives and Animal Nutrition
245 papers · 13.9% of this block
▼ -17% share2022→2025 share of research on this subject
Potential unintended effects of bioactive feed compounds on animal health and sustainability.
Feed additive · Animal feed · Feed conversion ratio · Health benefits
“Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production”
245 of these papers raise it as a problem
Cautions · theme 04
Food Contaminants and Regulatory Safety
240 papers · 13.6% of this block
▲ +14% share2022→2025 share of research on this subject
Uncertainties surrounding novel food ingredients, additives, and their safety assessments.
Food safety · Hygiene · Contamination · Food contaminant
“Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters”
240 of these papers raise it as a problem
Cautions · theme 05
DNA Damage and Repair Mechanisms
239 papers · 13.5% of this block
▼ -32% share2022→2025 share of research on this subject
Complexities in interpreting gene‑expression changes linked to genomic instability.
Gene · DNA damage · DNA repair · Gene expression
“Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations”
239 of these papers raise it as a problem
Cautions · theme 06
Antibiotic Use and Co‑Selection Pressures
206 papers · 11.7% of this block
▲ +10% share2022→2025 share of research on this subject
Risks of simultaneous resistance development to antibiotics, biocides, and metals.
Antibiotic resistance · Antibiotics · Antimicrobial · Bacteria
“Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses”
206 of these papers raise it as a problem
Cautions · theme 07
Pesticide Resistance Management
199 papers · 11.3% of this block
▲ +16% share2022→2025 share of research on this subject
Challenges in designing dose strategies to mitigate evolving pesticide resistance.
Pesticide · Integrated pest management · PEST analysis · Biological pest control
“The use of fungal entomopathogens as endophytes in biological control: a review”
199 of these papers raise it as a problem
Opportunities22,038 papers · 7 recurring themes
Opportunities · theme 01
Advanced Antibody and Imaging Techniques
1,044 papers · 17.4% of this block
▼ -18% share2022→2025 share of research on this subject
Emerging platforms for in‑vivo fluorescence, flow cytometry, and targeted immunotherapies.
Antibody · In vivo · Fluorescence · Flow cytometry
“Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom”
Opportunities · theme 02
Gene Regulation for Disease Intervention
1,032 papers · 17.2% of this block
▼ -26% share2022→2025 share of research on this subject
Promising approaches using knockdown, apoptosis control, and cell‑growth modulation.
Downregulation and upregulation · Apoptosis · Gene knockdown · Cell growth
“Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc”
Opportunities · theme 03
Functional Plant‑Based Foods
878 papers · 14.6% of this block
▲ +68% share2022→2025 share of research on this subject
Development of antioxidant‑rich ingredients and health‑promoting dietary products.
Health benefits · Functional food · Ingredient · Antioxidant
“Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives”
Opportunities · theme 04
Epigenetic and RNA‑Based Diagnostics
823 papers · 13.7% of this block
▼ -32% share2022→2025 share of research on this subject
Innovations in DNA methylation profiling and miRNA detection for disease monitoring.
Gene · DNA methylation · Messenger RNA · DNA damage
“Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders”
Opportunities · theme 05
Novel Antimicrobials and Biocontrol Agents
809 papers · 13.5% of this block
▲ +25% share2022→2025 share of research on this subject
Exploration of plant‑derived compounds and postbiotic products to combat resistance.
Antimicrobial · Antibiotic resistance · Biological pest control · Bacteria
“Plants as sources of new antimicrobials and resistance-modifying agents”
Opportunities · theme 06
Genetic Improvement of Germplasm
717 papers · 11.9% of this block
▼ -22% share2022→2025 share of research on this subject
Leveraging quantitative trait loci and selection to boost crop yields and traits.
Germplasm · Trait · Quantitative trait locus · Selection
“Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield”
Opportunities · theme 07
Sustainable Biomass and Biofuel Strategies
697 papers · 11.6% of this block
▲ +29% share2022→2025 share of research on this subject
Utilizing microbial fermentation and agri‑food by‑products for greener energy and materials.
Biomass · Sustainability · Agriculture · Biofuel
“Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health”
Which of these themes are growing fastest
The segment tracks how the share of research themes changes globally from 2022 to 2025.
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Food Safety and Processing Risks▲+41%
Plant Disease Management▲+35%
Crop Nutrition and Food Security▲+23%
Sustainable Biofuel and Biomass Production▲+11%
Antimicrobial Resistance Across Sectors▲+10%
Gene Expression and mRNA Therapeutics▼-31%
Miscellaneous Biological and Chemical Topics▼-32%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Genomic Selection in Plant Breeding▲+25%
Pesticide Resistance Management▲+16%
Food Contaminants and Regulatory Safety▲+14%
Antibiotic Use and Co‑Selection Pressures▲+10%
Feed Additives and Animal Nutrition▼-17%
Cellular Toxicity and Oxidative Stress▼-20%
DNA Damage and Repair Mechanisms▼-32%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Functional Plant‑Based Foods▲+68%
Sustainable Biomass and Biofuel Strategies▲+29%
Novel Antimicrobials and Biocontrol Agents▲+25%
Advanced Antibody and Imaging Techniques▼-18%
Genetic Improvement of Germplasm▼-22%
Gene Regulation for Disease Intervention▼-26%
Epigenetic and RNA‑Based Diagnostics▼-32%
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
Keep going
Track Life Sciences in the United Kingdom beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news and research trackers, covering the United Kingdom. Counts are of companies we track, not of every company that exists. Updated August 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.